Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Not yet recruiting · NCT07516561 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2026-09-08 | NCT07516561 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Apsen Farmaceutica S.A. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinica Geral Investiga Ltda | Campinas | Brazil | 1 |